PGR and cancer: A positive ER and/or PR, either positive HER2 or negative HER2, and high levels of Ki67 suggest a luminal B BCa subtype, which makes up less than 20% of all BCa cases and has lower survival rates than luminal A. The absence of ER and PR expression accompanied by high expression of HER2 and proliferation gene clusters and low expression of luminal and basal clusters, as detected by IHC, suggests a HER2-enriched BCa subtype, which accounts for 10% to 15% of all cases and has a poorer prognosis than luminal cancers.